NPHP1 and hepatocellular carcinoma: Consequently, when TMEM237 is overexpressed, the interaction between NPHP1 and PYK2 is enhanced, forming a ternary complex that activates the PYK2/ERK1/2 pathway in HCC cells, thereby promoting tumor progression (57).